 Itraconazole therapy nonmeningeal coccidioidomycosis clinical laboratory observations Itraconazole new oral triazole antifungal agent courses patients chronic coccidioidomycosis dosages mg/day median duration months Assessment efficacy scoring system Responses assessable courses Nonresponse patients previous therapy common pulmonary disease Toxicity minimal doses Pharmacokinetic analysis itraconazole serum steady state negligible circadian variation differences serum concentrations patients large Clinical isolates Coccidioides immitis uniform vitro susceptibility Itraconazole impressive activity series patients refractory coccidioidomycosis Further evaluation itraconazole systemic mycoses order